LONDON, October 25, 2018 /PRNewswire/ --
Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation today
A webcast of the presentation will be accessible live at 12:00pm ET and available to replay on Arix's website at https://arixbioscience.com/presentations.
For more information on the Event, please contact Arix.Event@burnsmc.com.
Enquiries For more information on Arix, please contact: Arix Bioscience plc Charlotte Parry, Head of Investor Relations +44(0)20-7290-1072 email@example.com
Optimum Strategic Communications Mary Clark, Supriya Mathur +44(0)203-714-1787 firstname.lastname@example.org
Burns McClellan (US Media & IR Enquiries) Bill Slattery Jr., Nancie Steinberg +1-212-213-0006 email@example.com
About Arix Bioscience plc Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.
Arix Bioscience plc is listed on the Main Market of the London Stock Exchange. For further information, please visit http://www.arixbioscience.com
SOURCE Arix Bioscience plc
Subscribe to our Free Newsletters!